Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

Share Price is delayed by 15 minutes
Get Live Data
90.00    0.00 (0.00%)
Bid:
88.00
Ask:
92.00
Spread: 4.00 (4.545%)
Market Cap: £101.01m
BBSN Live PriceLast checked at - London Stock Exchange

Intraday Brave Bison Share Chart

Director/PDMR Shareholding

29 Apr 2022 13:53

RNS Number : 9158J
Brave Bison Group PLC
29 April 2022
 

29 April 2022

 

Brave Bison Group plc

("Brave Bison" or the "Company")

 

 

Director/PDMR Shareholding

 

 

Brave Bison, the social and digital media company, announces that it has been notified that Philippa Norridge, Chief Financial Officer of the Company, has today purchased 111,111 ordinary shares in the Company at a price of 1.8 pence per ordinary share. Following this purchase, Philippa Norridge is interested in 851,111 ordinary shares in the Company, representing approximately 0.1 per cent. of the Company's issued ordinary share capital.

 

The notification below, made in accordance with the UK Market Abuse Regulation, provides further details.

 

For further information please contact:

 

Brave Bison Group plc

Oliver Green, Executive Chairman via Cenkos

Theo Green, Chief Growth Officer

Philippa Norridge, Chief Financial Officer

 

Cenkos Securities plc Tel: +44 (0)20 7397 8900

Nominated Adviser & Broker

Nicholas Wells

Ben Jeynes

 

 

 

 

 1

Details of the person discharging managerial responsibilities / person closely associated (PCA)

a)

Name

Philippa Norridge

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b) 

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Brave Bison Group plc

b)

LEI

213800BEII7EWIN8X308

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

ordinary shares of 0.1p each

 

 

Identification code (ISIN) for Brave Bison Group plc ordinary shares: GB00BF8HJ774

 

b)

Nature of the transaction

Acquisition of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1.8 pence

 

 

111,111

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

N/A - single transaction

e)

Date of the transaction

29 April 2022

f)

Place of the transaction

AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLKLFLLZLEBBF
Date   Source Headline
17th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20259:00 amRNSDirector/PDMR Shareholding
14th Jul 202512:15 pmRNSResult of General Meeting and Total Voting Rights
10th Jul 20259:40 amRNSIssue of Equity and Total Voting Rights
10th Jul 20257:00 amRNSHolding(s) in Company
7th Jul 20252:24 pmRNSHolding(s) in Company
27th Jun 20254:00 pmRNSResult of Annual General Meeting
27th Jun 20257:00 amRNSAGM Statement
26th Jun 20258:32 amRNSHolding(s) in Company
25th Jun 20257:00 amRNSAcquisition of MiniMBA
19th Jun 20257:00 amRNSExtension to Exclusivity
6th Jun 20257:00 amRNSAnnual Report, Notice of AGM & Change to Dividend
28th May 20257:00 amRNS-RPrimark Appoint SocialChain As Social Media Agency
9th May 20259:30 amRNSCompletion of Acquisition of The Fifth Group
9th May 20257:00 amRNSResponse to Press Speculation
23rd Apr 20258:30 amRNSExercise of Share Options
10th Apr 20257:01 amRNSAcquisition & Strategic Investment from News Corp.
10th Apr 20257:00 amRNSFinal Results
27th Mar 20257:00 amRNSAcquisition of Builtvisible
17th Mar 20257:00 amRNSNotice of Results & Investor Presentation
27th Jan 20257:00 amRNSTrading Update
9th Dec 20247:00 amRNSAcquisition & Trading Update
21st Oct 20247:00 amRNSReduction of Capital Effective
9th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20247:00 amRNSNotice of Results & Investor Presentation
20th Aug 20246:00 pmRNSHolding(s) in Company
7th Aug 20243:30 pmRNSExercise of options and issue of equity
22nd Jul 20248:05 amRNSTrading Update
19th Jun 20244:00 pmRNSResult of AGM
19th Jun 20247:00 amRNSAGM Statement
10th Jun 20243:03 pmRNSForm 8.3 - Brave Bison Group PLC
10th Jun 20248:56 amRNSRESPONSE TO RULE 2.8 ANNOUNCEMENT BY BRAVE BISON
10th Jun 20248:56 amRNSForm 8.5 (EPT/NON-RI)
10th Jun 20247:00 amRNSUpdate on Possible Offer for The Mission Group plc
7th Jun 20248:59 amRNSForm 8.5 (EPT/NON-RI)
6th Jun 202410:10 amRNSForm 8.5 (EPT/NON-RI) - Brave Bison Group PLC
6th Jun 20249:08 amRNSRESPONSE TO REVISED POSSIBLE OFFER ANNOUNCEMENT
5th Jun 20249:40 amRNSForm 8.5 (EPT/NON-RI)
4th Jun 20249:10 amRNSForm 8.5 (EPT/NON-RI)
4th Jun 20249:09 amRNSForm 8.3 - Brave Bison Group PLC
4th Jun 20247:00 amRNSRESPONSE TO REVISED POSSIBLE OFFER ANNOUNCEMENT
3rd Jun 20244:00 pmRNSForm 8.3 - Brave Bison Group PLC
3rd Jun 20243:52 pmRNSUpdate on Possible Offer for Mission
3rd Jun 20241:00 pmRNSForm 8.3 - Brave Bison Group PLC
3rd Jun 20248:52 amRNSForm 8.5 (EPT/NON-RI)
31st May 20242:22 pmRNSForm 8.5 (EPT/NON-RI) - AMENDMENT
31st May 20247:52 amRNSForm 8.5 (EPT/NON-RI)
30th May 20249:56 amRNSForm 8.5 (EPT/NON-RI)
29th May 202410:29 amRNSForm 8.3 - BRAVE BISON GROUP plc
29th May 202410:05 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.